Partners

Hemerion has been developing cancer-fighting therapies from 2010 on. Our team is supported by a consistent network of scientific, clinical and financial partners.

Clinical development

Mount Sinai Health System logo

Mount Sinai Health System

Mount Sinai Health System encompasses the Icahn School of Medicine and eight hospital campuses in the New York metropolitan area. Mount Sinai Health System will host several clinical trials of the Hemerion technology.

CHU Lille Logo

Centre Hospitalo-Universitaire de Lille

As the regional referral centre and major teaching hospital, Lille University Hospital provides the highest quality care to the North of France. Lille University Hospital has sponsored the first clinical trial evaluating the Hemerion technology.

Research & Development

Inserm, Lille University, OncoThAI logos

INSERM / OncoThai / Lille University

Hemerion develops technologies that originate from the research in Photodynamic Therapies led by the Onco ThAI team, a joint research group gathering Inserm, the University of Lille and the Lille University Hospital.

Logo SATT Nord

SATT Nord

SATT manages the technology transfer from french publicly funded research toward industry.

Strategic support

Logo Eurasanté

Eurasanté

Eurasanté is a development agency dedicated to tech transfer and business development in the life sciences sector.

Neigborhood logo

Neighborhood

Neighborhood is a life science innovation center that offers tailored mentoring, coaching and global access to health tech entrepreneurs.

Financing

Hemerion is funded by a wide network of public and private investors.